세계의 동물 모델 시장 - 산업 규모, 점유율, 동향, 기회, 예측, 동물 유형별, 용도별, 유통 채널별, 지역별, 경쟁별(2020-2030년)

Animal Model Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Animal Type, By Application, By Distribution Channel By Region and Competition, 2020-2030F

US $ 4,500 ￦ 6,174,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 5,500 ￦ 7,546,000

PDF and Excel (Multi-User License)

PDF 및 Excel 보고서를 기업의 팀이나 기관에서 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다.

US $ 8,000 ￦ 10,976,000

PDF and Excel (Custom Research License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다. 80시간의 애널리스트 타임이 포함되어 있고 Copy & Paste 가능한 PPT 버전도 제공됩니다. 짧은 Bespoke 리서치 프로젝트 수행에 맞는 라이선스입니다.

한글목차

동물 모델 세계 시장은 2024년에 18억 9,000만 달러였으며, 예측 기간 중 CAGR은 8.12%를 나타낼 전망이며, 2030년까지는 30억 2,000만 달러에 달할 것으로 예측되고 있습니다.

세계의 동물 모델 시장은 생명과학 산업 중에서도 역동적이고 빠르게 발전하고 있는 분야이며, 생물의학 연구와 시장 개척을 위한 중요한 도구로서 기능하고 있습니다. 마우스, 쥐, 영장류 등 폭넓은 동물종을 포함한 동물 모델은 인간의 생리적 및 병리학적 상태를 모방하기 위해 이용되고 있으며, 과학자는 질환의 연구나 잠재적인 치료법의 검증, 생물학적 메커니즘에 관한 귀중한 지견을 얻을 수 있습니다. 세계 동물 모델 시장은 제약 및 생명공학 연구에 대한 투자 증가, 개인화된 의료에 대한 수요 증가, 혁신적인 치료법 및 백신의 필요성으로 인해 상당한 성장이 예상됩니다.

시장 개요
예측 기간	2026-2030년
시장 규모 : 2024년	18억 9,000만 달러
시장 규모 : 2030년	30억 2,000만 달러
CAGR : 2025-2030년	8.12%
급성장 부문	쥐
최대 시장	북미

주요 시장 성장 촉진요인

만성 질환 증가

주요 시장 과제

윤리적 우려와 동물복지 개발

주요 시장 동향

비설치류 모델의 발전

목차

제1장 제품 개요

제2장 조사 방법

제3장 주요 요약

제4장 세계의 동물 모델 시장 전망

• 시장 규모와 예측
  • 금액별
• 시장 점유율 및 예측
  • 동물 유형별(쥐, 라트, 기니피그, 토끼, 햄스터, 기타)
  • 용도별(암, 면역 질환, 감염증, 기타)
  • 유통 채널별(제약 및 바이오테크놀러지 기업, 학술 연구 기관, 계약 연구 기관)
  • 지역별
  • 기업별(2024년)
• 시장 맵
  • 동물 유형별
  • 용도별
  • 유통 채널별
  • 지역별

제5장 아시아태평양 동물 모델 시장 전망

• 시장 규모와 예측
  • 금액별
• 시장 점유율 및 예측
  • 동물 유형별
  • 용도별
  • 유통 채널별
  • 국가별
• 아시아태평양: 국가별 분석
  • 중국
  • 인도
  • 호주
  • 일본
  • 한국

제6장 유럽 동물 모델 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 유럽 : 국가별 분석
  • 독일
  • 스페인
  • 이탈리아
  • 영국

제7장 북미의 동물 모델 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 북미 : 국가별 분석
  • 멕시코
  • 캐나다

제8장 남미의 동물 모델 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 남미 : 국가별 분석
  • 아르헨티나
  • 콜롬비아

제9장 중동 및 아프리카 동물 모델 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 중동 및 아프리카: 국가별 분석
  • 사우디아라비아
  • 아랍에미리트(UAE)

제10장 시장 역학

• 성장 촉진요인
• 과제

제11장 시장 동향과 발전

• 최근 동향
• 제품 출시
• 합병과 인수

제12장 세계 동물 모델 시장 : SWOT 분석

제13장 Porter's Five Forces 분석

• 업계 내 경쟁
• 신규 진입의 가능성
• 공급자의 힘
• 고객의 힘
• 대체품의 위협

제14장 경쟁 구도

• Charles River Laboratories
• The Jackson Laboratory
• genOway
• Taconic Biosciences, Inc.
• Janvier Labs
• Harbour BioMed
• Crown Bioscience
• Inotiv
• BIOCYTOGEN
• BioSpherix, Ltd.

제15장 전략적 제안

제16장 기업 소개와 면책사항

SHW

영문 목차

영문목차

Global Animal Model Market was valued at USD 1.89 billion in 2024 and and is expected to reach USD 3.02 billion by 2030 with a CAGR of 8.12% during the forecast period. The global animal model market is a dynamic and rapidly evolving sector of the life sciences industry, serving as a crucial tool for biomedical research and drug development. Animal models, which include a wide range of species from mice and rats to primates, are utilized to mimic human physiological and pathological conditions, enabling scientists to study diseases, test potential treatments, and gain valuable insights into biological mechanisms. The global animal model market is poised for substantial growth due to increasing investments in pharmaceutical and biotechnology research, rising demand for personalized medicine, and the need for innovative therapies and vaccines.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 1.89 Billion
Market Size 2030	USD 3.02 Billion
CAGR 2025-2030	8.12%
Fastest Growing Segment	Mice
Largest Market	North America

Key Market Drivers

Rising Prevalence of Chronic Diseases

The rising prevalence of chronic diseases is a significant factor propelling the growth of the global animal model market. Chronic diseases, including cancer, diabetes, cardiovascular conditions, and neurological disorders, have reached epidemic proportions worldwide, imposing a substantial burden on healthcare systems and economies. In response to this health crisis, there is an ever-increasing demand for effective treatments and therapies. Animal models are at the forefront of preclinical research, providing a vital tool for understanding disease mechanisms and testing potential interventions.

According to WHO, Noncommunicable diseases (NCDs) killed at least 43 million people in 2021, equivalent to 75% of non-pandemic-related deaths globally. In 2021, 18 million people died from an NCD before age 70 years; 82% of these premature deaths occur in low- and middle-income countries. Cardiovascular diseases account for most NCD deaths, or at least 19 million deaths in 2021, followed by cancers (10 million), chronic respiratory diseases (4 million), and diabetes (over 2 million including kidney disease deaths caused by diabetes).

Animal models serve as invaluable surrogates for human physiology, offering a means to simulate the complexities of chronic diseases and study their progression. Researchers can replicate the pathophysiological processes within animals, allowing for the investigation of disease etiology, drug efficacy, and safety profiles. This capability significantly reduces the inherent risks of advancing unproven therapies directly to human clinical trials.

Moreover, the use of animal models enables researchers to explore novel therapeutic avenues, develop innovative drug candidates, and fine-tune treatment regimens. By replicating the pathological conditions of chronic diseases in animal subjects, scientists can gain insights into potential therapeutic targets and mechanisms that would be challenging to investigate in any other way.

Key Market Challenges

Development of Ethical Concerns and Animal Welfare

The global animal model market, a linchpin of biomedical research and drug development, faces a formidable challenge from the escalating ethical concerns surrounding animal welfare. As society becomes increasingly conscious of the moral implications of using animals in research, these concerns have the potential to hinder the growth and evolution of the animal model market.

One of the central challenges is the ethical dilemma associated with animal experimentation. Many individuals, animal welfare organizations, and advocacy groups contend that the use of animals in research raises serious ethical questions regarding the treatment and suffering of sentient beings. The debate over the morality of using animals for scientific experiments has led to increasing calls for more stringent regulations and the development of alternative methods that do not involve animals.

As ethical concerns grow, there is greater scrutiny of animal welfare in research settings. Researchers are under increasing pressure to improve animal care, reduce suffering, and minimize the use of animals whenever possible. This, in turn, has raised the bar for standards and practices in the field, leading to more rigorous requirements for housing, enrichment, and veterinary care of research animals. These higher standards often translate into additional costs for research institutions and organizations.

Key Market Trends

Advancements in Non-Rodent Models

Advancements in non-rodent models are emerging as a significant driver behind the growth of the global animal model market. While rodents, particularly mice and rats, have traditionally been the primary subjects of animal research, there is a growing trend towards diversification as researchers seek more physiologically relevant models that closely mimic human biology. Non-human primates, pigs, dogs, and other species are becoming increasingly valuable in various research applications, driving the market's expansion and adaptability.

Non-rodent animal models offer several advantages. They provide a closer approximation of human physiology, making them crucial for translational research where the goal is to bridge the gap between preclinical studies and human clinical trials. For example, non-human primates share a closer genetic and physiological resemblance to humans, making them invaluable in the development of therapies for diseases with complex genetic and immunological components.

Key Market Players

• Charles River Laboratories
• The Jackson Laboratory
• genOway
• Taconic Biosciences, Inc.
• Janvier Labs
• Harbour BioMed
• Crown Bioscience
• Inotiv
• BIOCYTOGEN
• BioSpherix, Ltd

Report Scope:

In this report, the Global Animal Model Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Animal Model Market, By Animal Type:

• Mice
• Rat
• Guinea Pigs
• Rabbits
• Hamsters
• Others

Animal Model Market, By Application:

• Cancer
• Immunological Disease
• Infectious Disease
• Others

Animal Model Market, By Distribution Channel:

• Pharmaceutical & Biotechnology Companies
• Academic Research Institute
• Contract Research Organization

Animal Model Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Animal Model Market.

Available Customizations:

Global Animal Model Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Animal Model Market Outlook

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
• 4.2. Market Share & Forecast
  • 4.2.1. By Animal Type (Mice, Rat, Guinea Pigs, Rabbits, Hamsters, Others)
  • 4.2.2. By Application (Cancer, Immunological Disease, Infectious Disease, Others)
  • 4.2.3. By Distribution Channel (Pharmaceutical & Biotechnology Companies, Academic Research Institute, Contract Research Organization)
  • 4.2.4. By Region
  • 4.2.5. By Company (2024)
• 4.3. Market Map
  • 4.3.1. By Animal Type
  • 4.3.2. By Application
  • 4.3.3. By Distribution Channel
  • 4.3.4. By Region

5. Asia Pacific Animal Model Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Animal Type
  • 5.2.2. By Application
  • 5.2.3. By Distribution Channel
  • 5.2.4. By Country
• 5.3. Asia Pacific: Country Analysis
  • 5.3.1. China Animal Model Market Outlook
    • 5.3.1.1. Market Size & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share & Forecast
      • 5.3.1.2.1. By Animal Type
      • 5.3.1.2.2. By Application
      • 5.3.1.2.3. By Distribution Channel
  • 5.3.2. India Animal Model Market Outlook
    • 5.3.2.1. Market Size & Forecast
      • 5.3.2.1.1. By Value
    • 5.3.2.2. Market Share & Forecast
      • 5.3.2.2.1. By Animal Type
      • 5.3.2.2.2. By Application
      • 5.3.2.2.3. By Distribution Channel
  • 5.3.3. Australia Animal Model Market Outlook
    • 5.3.3.1. Market Size & Forecast
      • 5.3.3.1.1. By Value
    • 5.3.3.2. Market Share & Forecast
      • 5.3.3.2.1. By Animal Type
      • 5.3.3.2.2. By Application
      • 5.3.3.2.3. By Distribution Channel
  • 5.3.4. Japan Animal Model Market Outlook
    • 5.3.4.1. Market Size & Forecast
      • 5.3.4.1.1. By Value
    • 5.3.4.2. Market Share & Forecast
      • 5.3.4.2.1. By Animal Type
      • 5.3.4.2.2. By Application
      • 5.3.4.2.3. By Distribution Channel
  • 5.3.5. South Korea Animal Model Market Outlook
    • 5.3.5.1. Market Size & Forecast
      • 5.3.5.1.1. By Value
    • 5.3.5.2. Market Share & Forecast
      • 5.3.5.2.1. By Animal Type
      • 5.3.5.2.2. By Application
      • 5.3.5.2.3. By Distribution Channel

6. Europe Animal Model Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Animal Type
  • 6.2.2. By Application
  • 6.2.3. By Distribution Channel
  • 6.2.4. By Country
• 6.3. Europe: Country Analysis
  • 6.3.1. France Animal Model Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Animal Type
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By Distribution Channel
  • 6.3.2. Germany Animal Model Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Animal Type
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By Distribution Channel
  • 6.3.3. Spain Animal Model Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Animal Type
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By Distribution Channel
  • 6.3.4. Italy Animal Model Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Animal Type
      • 6.3.4.2.2. By Application
      • 6.3.4.2.3. By Distribution Channel
  • 6.3.5. United Kingdom Animal Model Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Animal Type
      • 6.3.5.2.2. By Application
      • 6.3.5.2.3. By Distribution Channel

7. North America Animal Model Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Animal Type
  • 7.2.2. By Application
  • 7.2.3. By Distribution Channel
  • 7.2.4. By Country
• 7.3. North America: Country Analysis
  • 7.3.1. United States Animal Model Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Animal Type
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By Distribution Channel
  • 7.3.2. Mexico Animal Model Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Animal Type
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By Distribution Channel
  • 7.3.3. Canada Animal Model Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Animal Type
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By Distribution Channel

8. South America Animal Model Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Animal Type
  • 8.2.2. By Application
  • 8.2.3. By Distribution Channel
  • 8.2.4. By Country
• 8.3. South America: Country Analysis
  • 8.3.1. Brazil Animal Model Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Animal Type
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By Distribution Channel
  • 8.3.2. Argentina Animal Model Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Animal Type
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By Distribution Channel
  • 8.3.3. Colombia Animal Model Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Animal Type
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By Distribution Channel

9. Middle East and Africa Animal Model Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Animal Type
  • 9.2.2. By Application
  • 9.2.3. By Distribution Channel
  • 9.2.4. By Country
• 9.3. MEA: Country Analysis
  • 9.3.1. South Africa Animal Model Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Animal Type
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By Distribution Channel
  • 9.3.2. Saudi Arabia Animal Model Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Animal Type
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By Distribution Channel
  • 9.3.3. UAE Animal Model Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Animal Type
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By Distribution Channel

10. Market Dynamics

• 10.1. Drivers
• 10.2. Challenges

11. Market Trends & Developments

• 11.1. Recent Developments
• 11.2. Product Launches
• 11.3. Mergers & Acquisitions

12. Global Animal Model Market: SWOT Analysis

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Product

14. Competitive Landscape

• 14.1. Charles River Laboratories
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (In case of listed)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. The Jackson Laboratory
• 14.3. genOway
• 14.4. Taconic Biosciences, Inc.
• 14.5. Janvier Labs
• 14.6. Harbour BioMed
• 14.7. Crown Bioscience
• 14.8. Inotiv
• 14.9. BIOCYTOGEN
• 14.10.BioSpherix, Ltd.

15. Strategic Recommendations

16. About Us & Disclaimer

관련자료